Quince Therapeutics Inc’s stock market performance has been consistent. The 1-year high for the company’s stock was recorded at $1.79 on 11/14/24, with the lowest value being $0.51 on 08/15/24.
52-week price history of QNCX Stock
Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Quince Therapeutics Inc’s current trading price is 6.15% away from its 52-week high, while its distance from the 52-week low is 271.38%. The stock’s price range for this period has remained between $0.51 and $1.79. The Healthcare sector company’s shares managed to surpass a trading volume of around 0.57 million for the day, which was noticeably higher compared to the shares’ average daily volume of 0.55 million over the last three months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Financial Performance and Market Capitalization
Quince Therapeutics Inc (QNCX) has experienced a quarterly rise of 246.27% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 82.23M and boasts a workforce of 32 employees.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.8457, with a change in price of +1.2125. Similarly, Quince Therapeutics Inc recorded 388,649 in trading volume during the last 100 days, posting a change of +176.36%.
QNCX Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for QNCX stands at 0.34. Similarly, the long-term debt-to-equity ratio is also 0.34.
QNCX Stock Stochastic Average
As of today, the raw stochastic average of Quince Therapeutics Inc over the last 50 days is at 96.08%. This shows a increasee from the raw stochastic average of the previous 20 days, which was recorded at 95.83%. Further, the company’s Stochastic %K and %D values for the last 20 days were 88.80% and 88.25%, respectively.
QNCX Stock Price Performance Analysis
The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. The metric has seen a significant gain of 80.95% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 106.54%. Over the past 30 days, the price of QNCX has fallen by 131.99%. And in the last five days, it has surged by 23.38%.
